ATE110787T1 - Bestimmung von bakteriuria. - Google Patents

Bestimmung von bakteriuria.

Info

Publication number: ATE110787T1
Authority: AT; Austria
Prior art keywords: bacteria; urine; detected; examination; bacteriuria
Prior art date: 1987-06-12

Application number

AT87305254T

Other languages

English (en)

Inventor

Edward S Hyman

Original Assignee

Edward S Hyman

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-06-12

Filing date

1987-06-12

Publication date

1994-09-15

1987-06-12 Application filed by Edward S Hyman filed Critical Edward S Hyman

1994-09-15 Application granted granted Critical

1994-09-15 Publication of ATE110787T1 publication Critical patent/ATE110787T1/de

Links

201000004538 Bacteriuria Diseases 0.000 title 1
241000894006 Bacteria Species 0.000 abstract 5
210000002700 urine Anatomy 0.000 abstract 4
238000000034 method Methods 0.000 abstract 3
238000002360 preparation method Methods 0.000 abstract 2
208000007530 Essential hypertension Diseases 0.000 abstract 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
229910019142 PO4 Inorganic materials 0.000 abstract 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
230000003115 biocidal effect Effects 0.000 abstract 1
238000005119 centrifugation Methods 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 abstract 1
229960002227 clindamycin Drugs 0.000 abstract 1
239000000470 constituent Substances 0.000 abstract 1
239000008103 glucose Substances 0.000 abstract 1
230000002452 interceptive effect Effects 0.000 abstract 1
150000002632 lipids Chemical class 0.000 abstract 1
238000012986 modification Methods 0.000 abstract 1
230000004048 modification Effects 0.000 abstract 1
235000021317 phosphate Nutrition 0.000 abstract 1
150000003013 phosphoric acid derivatives Chemical class 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
239000013049 sediment Substances 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Organic Chemistry (AREA)
Biochemistry (AREA)
Analytical Chemistry (AREA)
Cell Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Food Science & Technology (AREA)
Zoology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Medicinal Chemistry (AREA)
Wood Science & Technology (AREA)
Toxicology (AREA)
Tropical Medicine & Parasitology (AREA)
Biophysics (AREA)
Rheumatology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Rehabilitation Therapy (AREA)
Virology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Eye Examination Apparatus (AREA)
Peptides Or Proteins (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT87305254T 1987-06-12 1987-06-12 Bestimmung von bakteriuria. ATE110787T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP87305254A EP0294529B1 (de)	1987-06-12	1987-06-12	Bestimmung von Bakteriuria

Publications (1)

Publication Number	Publication Date
ATE110787T1 true ATE110787T1 (de)	1994-09-15

Family

ID=8197944

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT87305254T ATE110787T1 (de)	1987-06-12	1987-06-12	Bestimmung von bakteriuria.

Country Status (3)

Country	Link
EP (1)	EP0294529B1 (de)
AT (1)	ATE110787T1 (de)
DE (1)	DE3750474T2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4992365A (en) *	1984-04-23	1991-02-12	Hyman Edward S	Method of detecting bacteria in urine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS54119992A (en) *	1978-03-10	1979-09-18	Lion Dentifrice Co Ltd	Reagent for measuring quantity of bacteria relating to disease around tooth
CA1112987A (en) *	1978-09-25	1981-11-24	Joseph L. Melnick	Staining and analysis of bacteria
DE3048294A1 (de) *	1980-12-20	1982-07-08	Carlos Prof. Dr. 7808 Waldkirch Thomas	"verfahren und vorrichtung zur entwaesserung und/oder entfettung von gewebeproben"
HU184903B (en) *	1981-11-20	1984-11-28	Reanal Finomvegyszergyar	Paint composition for biopsy examinations

1987
- 1987-06-12 AT AT87305254T patent/ATE110787T1/de active
- 1987-06-12 DE DE3750474T patent/DE3750474T2/de not_active Expired - Fee Related
- 1987-06-12 EP EP87305254A patent/EP0294529B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE3750474T2 (de)	1994-12-22
DE3750474D1 (de)	1994-10-06
EP0294529B1 (de)	1994-08-31
EP0294529A1 (de)	1988-12-14

Similar Documents

Publication	Publication Date	Title
Nottebrock et al.	1977	Thymidine concentrations in serum and urine of different animal species and man
Diaz et al.	1977	Bullous pemphigoid antigen: isolation from normal human skin
Lou et al.	1989	A STUDY ON Tea-Pigmentin Prevention of Atherosclerosis
AU3575089A (en)	1990-01-23	Method of detecting bacteria in urine
FR2623509B1 (fr)	1990-04-20	Proteine de 17 kd a action angiogenique, son procede d'isolement a partir de lait de mammiferes, compositions therapeutiques la contenant, procede de detection et/ou de dosage et reactifs immunologiques de detection et de dosage des angiogenines de mammiferes, de leurs homologues et de leurs fragments
DE3205301C2 (de)	1991-07-04
DE3478958D1 (en)	1989-08-17	Protein conjugates of penicilloic acid, their preparation and use
ATE110787T1 (de)	1994-09-15	Bestimmung von bakteriuria.
Kirkpatrick Jr et al.	1978	Whipple's disease: a case report with immunological studies
ATE105086T1 (de)	1994-05-15	Diagnostisches mittel und verfahren zur bestimmung von apolipoprotein b.
EP0070656B1 (de)	1986-09-24	Immobilisierte Superoxyd-dismutase, ihre Herstellung und pharmazeutische Zusammensetzung
Miller	1957	Studies on an interaction among serum protein, materials containing intrinsic factor and vitamin B12
NO173336C (no)	1993-12-01	Fremgangsm}te til isolering av basalmembranproteiner fra human- eller animalvev og anvendelse av det oppn}dde protein
FR2608767B1 (fr)	1991-04-05	Procede pour la detection et le dosage des anticorps anti-(sporozoaires de p. falciparum) dans le sang humain et trousses de diagnostic pour mettre en oeuvre ce procede
Fiszer-Szafarz et al.	1970	Hyaluronic acid content of the interstitial fluid of Walker carcinoma 256
Witebsky et al.	1935	Distribution of blood group properties and blood group property destroying factors in the intestinal tract of man
Angel et al.	1963	A controlled comparison of cycloserine plus ethionamide with cycloserine plus thiacetazone in patients with active pulmonary tuberculosis despite prolonged previous chemotherapy
Burioni et al.	1988	Lyme disease in Italy: isolation of Borrelia burgdorferi from a patient
Kamboh et al.	1986	Genetic studies of low-abundance human plasma proteins. I. Microheterogeneity of zinc-α 2-glycoprotein in biological fluids
Williams et al.	1972	Soluble Serum Antigens of P. falciparum in Nigerians
Yaegaki et al.	1982	Influence of aging on DNase activity in human parotid saliva
Horowitz et al.	1961	Blood group substances in canine gastric mucus and acid secretion.
SE8701437D0 (sv)	1987-04-06	Diagnostiskt forfarande in vitro samt medel som kan utnyttjas vid forfarandet
Walter et al.	1966	Effect of oxidized glutathione on some enzymes of erythrocytes and its relation to erythrocytic enzyme activity and electrophoretic mobility
Hall et al.	1964	Improved method for the extraction of vitamin B12 from serum